John P. Scheibeler
John is an experienced U.S. patent attorney focusing on litigation and counseling. He represents life science clients and high-tech in U.S. patent infringement cases, trade secret misappropriation cases, inter partes reviews, post-grant reviews, and various counseling matters. He has represented client in numerous cases before the U.S. District Courts, the U.S. Court of Appeals for the Federal Circuit and the U.S. Patent Trial and Appeal Board.
John's life science litigation experience includes Hatch-Waxman (ANDA) and other patent litigation for several leading pharmaceutical companies, biosimilar matters governed by the Biologics Price Competition and Innovation Act, and inter parties review and post-grant review proceedings. He has also assisted life science clients managing multi-country litigation.
John's high-tech litigation experience includes patent infringement cases in the U.S. District Courts, International Trade Commission, as well as inter partes and post-grant reviews before the U.S. Patent Trial and Appeal Board.
John has significant experience counseling clients in procuring patent protection, licensing patent rights, investigating freedom-to-operate issues, and assisting in due-diligence investigations for corporate transactions.
John works in the Firm's New York office.
British Telecommunications plc v. Google Inc.
Represent defendant in patent infringement litigation alleging infringement of five patents by numerous Google products.
BRK Brands, Inc. v. Nest Labs, Inc.
Represent defendant in patent infringement litigation alleging infringement of multiple patents by defendant's smart home smoke/carbon monoxide detectors.
Certain Communications or Computing Devices, and Components Thereof
Represent Google as intervenor in 337 action in the International Trade Commission in which complainant asserted infringement of four patents by various applications and the operating system of mobile devices.
Pfizer Inc et al. v. Teva Pharmaceuticals U.S.A., Inc.
Represent plaintiff in Hatch Waxman litigation against multiple defendants involving the blockbuster drug Lyrica®.
Item Dev. AB v. Sicor, Inc. et al.
Represent patent holder in ANDA patent infringement litigation involving AdenoScan®, a drug used to help identify areas of heart damage.